Top Markets
Coin of the day
Shine-On BioMedical Co.,Ltd. Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co.,Ltd.

6926
Rang in Aktien #21821
Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and... Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and manufacturing of pharmaceutical products aimed at combating cancer. The company's innovative pipeline features a range of antibody-based oncology therapies. These include exosome anti-cancer drugs like SOB101 and SOB102, as well as SOB201, an engineered multi-target exosome. Additionally, their portfolio encompasses specialized antibody treatments such as SOA101, a dual immune checkpoint T cell adapter, and SOA201, a trispecific adapter immune cell antibody. This Taiwanese firm, founded in 2021, is based in Taichung.
Aktienkurs
$2.00
Zuletzt synchronisiert: 2026-08-20
Marktkapitalisierung
$99.77M
Veränderung (1 Tag)
-0.47%
Veränderung (1 Jahr)
-15.35%
Land
TW
Handel Shine-On BioMedical Co.,Ltd. (6926)

Kategorie

Kursverlauf für Shine-On BioMedical Co.,Ltd. (6926)
Höchster Schlusskurs: $2.01 am 2026-08-01

Niedrigster Schlusskurs: $2.24 am 2022-11-01
Kursverlauf der Aktie von Shine-On BioMedical Co.,Ltd. von 2022 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -1.81%
2025 7.89%
2024 0.46%
2023 0.13%
2022 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH